The predictive value of combinations of different levels of brain natriuretic peptide and norepinephrine in the Val-HeFT trial

Inderiit S. Anand; Roberto Latini; Serge Masson; Dianne Judd; Aldo Maggioni; Robert Glazer; Tom Chiang; Philippe Lechat; Gianni Tognoni; Jay N. Cohn

doi:10.1016/s0735-1097(02)81207-4

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2003

Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT

Inder S. Anand, Lloyd D. Fisher, Yann-Tom Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2003

The relationship between B-type natriuretic peptide, heart structure, and function in 4,300 patients with heart failure enrolled to Val-HeFT

Roberto Latini, Serge Masson, Lidia Staszewsky, Aldo Maggioni, Alberto Volpi, Simona Barlera, Inder S. Anand, Allen Hester, Maylene Wong, Jay N. Cohn

Article2002

Effects of Valsartan on Circulating Brain Natriuretic Peptide and Norepinephrine in Symptomatic Chronic Heart Failure

Roberto Latini, Serge Masson, Inder S. Anand, Dianne Judd, Aldo Maggioni, YannTong Chiang, Maurizio Bevilacqua, Monica Salio, Paola Cardano, Peter H.J.M. Dunselman, Nicolaas J. Holwerda, Gianni Tognoni, Jay N. Cohn

Article2003

Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT

Inder S. Anand, Roberto Latini, Robert Glazer, Allen Hester, Serge Masson, Aldo Maggioni, Nora Aknay, Jay N. Cohn